GT Biopharma GTBP
NASDAQ GTBP
$6.10 -0.10 (-1.61%)
At close: Oct 2, 2026 · 4:00 PM EDT

GT Biopharma (GTBP) Selling, General & Administrative (2010 - 2026)

Updated

GT Biopharma's Selling, General & Administrative was $2.44 million in Q1 2026, up 192.3% from $833,000 a year earlier but down 42.3% from the prior quarter.

Analysis

GT Biopharma (GTBP) Selling, General & Administrative (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, GT Biopharma's Selling, General & Administrative was $10.55 million through Mar 31, 2026, up 48.9% year-over-year; for FY2025, it came in at $8.95 million, up 4.5% from FY2024.

  • Selling, General & Administrative shows a five-year compound annual growth rate of 7.3% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $8.57 million in FY2024 (+20.5%), $7.11 million in FY2023 (-42.9%), $12.45 million in FY2022 (-74.0%) and $47.92 million in FY2021 (+663.2%).
  • Quarterly Selling, General & Administrative has moved between $833,000 (Q1 2025) and $11.87 million (Q4 2021) over five years.
  • Compared with a year earlier, Selling, General & Administrative has increased for three straight quarters, with growth averaging 37.9% over the last eight quarters.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q4 2021 (growth of 506.4%); the worst was Q1 2022 (a decline of 87.7%).
  • Per Business Quant data, GTBP's Selling, General & Administrative in the three quarters before Q1 2026 was $4.22 million (Q4 2025), $2.75 million (Q3 2025) and $1.15 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 GT Biopharma 8.58 Mn 8.58 Mn - 2.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.44 Mn
Dec 31, 2025 4.22 Mn
Sep 30, 2025 2.75 Mn
Jun 30, 2025 1.15 Mn
Mar 31, 2025 833,000.00
Dec 31, 2024 1.83 Mn
Sep 30, 2024 2.30 Mn
Jun 30, 2024 2.12 Mn
Mar 31, 2024 2.31 Mn
Dec 31, 2023 1.81 Mn
Sep 30, 2023 1.76 Mn
Jun 30, 2023 1.53 Mn
Mar 31, 2023 2.02 Mn
Dec 31, 2022 2.94 Mn
Sep 30, 2022 4.28 Mn
Jun 30, 2022 1.88 Mn
Mar 31, 2022 3.36 Mn
Dec 31, 2021 11.87 Mn
Sep 30, 2021 4.95 Mn
Jun 30, 2021 3.74 Mn
API Access

GT Biopharma Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=GTBP&period=max&api_key=YOUR_API_KEY